CTC Alternative Strategies »

C4 Therapeutics shares owned by CTC Alternative Strategies

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by CTC Alternative Strategies from 13F filings

Historical chart of CTC Alternative Strategies investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by CTC Alternative Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by CTC Alternative Strategies

Quarter filed Position value Share count Share price at filing
2026-03-31 $28k 11k 2.63

More positions owned by CTC Alternative Strategies

Select Sector Spdr Tr State Street Com (XLC)
Coinbase Global Com Cl A (COIN)
Arm Holdings Sponsored Ads (ARM)
Broadcom (AVGO)
Select Sector Spdr Tr State Street Con (XLY)
NVIDIA Corporation (NVDA)
Technipfmc (FTI)
AFLAC Incorporated (AFL)
Medline Com Cl A (MDLN)
Autodesk (ADSK)
Tesla Motors (TSLA)
Wal-Mart Stores (WMT)
AutoZone (AZO)
Coreweave Com Cl A (CRWV)
Chime Finl Com Shs Cl A (CHYM)

View all positions for CTC Alternative Strategies

Top funds holding C4 Therapeutics

Morgan Stanley
RA Capital Management
Bain Capital Life Sciences Investors
Lynx1 Capital Management
Vanguard Group
Vanguard Capital Management
Soleus Capital Management
Two Sigma Investments
Daniel D. Thurber
Citadel Advisors
Goldman Sachs Group
Bank of America Corporation
Squadron Capital Management
BlackRock
Silverarc Capital Management

View all funds holding C4 Therapeutics